Skip to main content

Peer Review reports

From: Regorafenib monotherapy or combined with an immune-checkpoint inhibitor as later-line treatment for metastatic colorectal cancer: a multicenter, real-world retrospective study in China

Original Submission
24 Sep 2023 Submitted Original manuscript
15 Oct 2023 Reviewed Reviewer Report - Kazuo Kobayashi
29 Oct 2023 Reviewed Reviewer Report
11 Nov 2023 Author responded Author comments - Aiping Zhou
Resubmission - Version 2
11 Nov 2023 Submitted Manuscript version 2
13 Nov 2023 Author responded Author comments - Aiping Zhou
Resubmission - Version 3
13 Nov 2023 Submitted Manuscript version 3
14 Nov 2023 Author responded Author comments - Aiping Zhou
Resubmission - Version 4
14 Nov 2023 Submitted Manuscript version 4
26 Nov 2023 Reviewed Reviewer Report
Resubmission - Version 5
Submitted Manuscript version 5
Publishing
30 Nov 2023 Editorially accepted
2 Jan 2024 Article published 10.1186/s12885-023-11700-w

You can find further information about peer review here.

Back to article page